GLP-1药物对女性就业率的提升作用超过了大学学位
Study links GLP-1 drugs to bigger jump in women's employment than a degree

原始链接: https://finance.yahoo.com/healthcare/articles/harvard-study-links-glp-1-123000637.html

哈佛大学经济学家丽贝卡·戴蒙德(Rebecca Diamond)2026年的一项研究强调了体重偏见对女性经济前景的持续影响。研究表明,与尚未开始使用GLP-1减肥药物的女性相比,开始使用此类药物的女性在18个月后的就业率上升了近27个百分点——这一差距甚至超过了高中学历者与大学学历者之间的就业差距。 研究结果显示,这种增长很可能源于社会观念,而非个人技能或能力的实际变化。长期以来,有关“肥胖惩罚”的证据一直存在,研究表明,招聘经理往往会将体重较高的人不公平地贴上“懒惰”或“不专业”的标签。此外,该研究还指出,使用GLP-1的单身女性进入恋爱关系的几率显著增加。 归根结底,数据表明,在一个受“外貌红利”和基于外貌的偏见影响招聘及社会结果的文化中,减重可能会在无意中提升女性的经济流动性。然而,专家强调,这些结果反映的是根深蒂固的社会偏见,而非个人内在价值或专业素质的提升。

Hacker News 上近期的一项讨论探讨了一项新研究,该研究表明 GLP-1 减肥药物为女性带来了显著的就业优势。这一话题引发了关于“外貌歧视”、“光环效应”以及社会偏见的广泛辩论。 讨论的主要观点包括: * **就业与外貌:** 许多评论者认为,外貌(包括体重)是职业发展中一个重要且往往秘而不宣的因素。多位参与者分享了个人的经历,称在减轻体重或改善仪容后,在职业环境中受到了更多尊重,面临的阻力也随之减少。 * **“对照”实验:** 讨论中常将减肥与性别转换相提并论,参与者指出他们就像是自己的“对照组”,观察到同一个人会因外在形象的不同而受到不同的对待。 * **关于因果关系的辩论:** 一些人将这种职业收益归因于“光环效应”(即潜意识中偏袒外貌出众者的偏见);另一些人则指出,药物带来的能量提升、健康状况改善以及专注力的增强也是重要原因。 * **细微差别与质疑:** 一些用户提醒不要过度解读这项研究,指出相关性并不等于因果关系,且终身用药既有经济负担,也存在潜在的长期风险。
相关文章

原文
shutterstock.com / Pietukhova

Pretty privilege may be alive and well. Apparently, so is skinny privilege.

For years, economists have documented what they call the "obesity penalty" — the social and financial disadvantages people can face because of their weight. Now, the rise of GLP-1 medications is giving researchers a new way to measure just how much appearance may shape someone's economic prospects.

Must Read

In a 2026 working paper published by the National Bureau of Economic Research, Harvard economist Rebecca Diamond found that women who were unemployed when they began taking GLP-1 medications saw a change 18 months later.

Their employment rate rose by nearly 27 percentage points compared with women who wanted to take the medications but had not yet started – a gap larger than the employment difference between American women with a high school diploma and those with a university degree.

The research does not suggest that losing weight made these women smarter, more capable or better qualified for work. Instead, it raises questions about whether changes in appearance may affect how women are perceived by employers.

The financial cost of weight bias

GLP-1 medications have quickly become a popular weight-loss tool. In 2026, 11% of U.S. adults said they were currently taking one to lose weight, up from just 3% in 2024, according to Gallup.

But long before GLP-1s became part of the cultural conversation, research suggested weight was already influencing how women were perceived in the workplace.

A report from Fairygodboss, an employer review site for women, offered a particularly troubling look at how appearance can shape hiring decisions. In one study, hiring professionals were shown images of women with different body types and asked to evaluate them.

The heaviest-looking woman was judged much more harshly. Twenty percent of respondents described her as "lazy," a label applied less frequently to every other woman pictured. Just 18% said she appeared to have leadership potential, while 21% described her as "unprofessional."

Read More: Vanguard reveals what's coming for U.S. stocks — and it could be bad news for this group of investors

What the data shows

Diamond looked at survey data from about 15,000 people. She compared women who started taking GLP-1 medications with similar women who wanted to take them but had not started yet. The groups were matched based on factors such as income, race, body mass index and overall health.

The study found changes in women's personal lives, too. Single women taking GLP-1s were nearly 29 percentage points more likely to get married or move in with a partner than similar women who had not started the medications.

The findings also add to years of research suggesting that body weight can influence how women are treated financially.

In 2011, the Federal Reserve Bank of St. Louis cited research finding that overweight white women earned about 4.5% less than white women whose BMI fell within what researchers classified as the normal range. White women with obesity earned nearly 12% less.

Those figures were specific to white women and do not apply to everyone. They also do not show that body size determines someone's value or ability. Rather, they suggest weight-related bias was showing up in some women's pay long before GLP-1 medications became popular.

When pretty privilege pays

Codie Sanchez, CEO and founder of Contrarian Thinking, has said women who wear makeup to work earn about 30% more on average than women who don't.

"Pretty privilege is very real," she said on an episode of The Burnouts Podcast. "And you can either say 'That's not fair, so I'm not doing it.' or you can win."

Sanchez acknowledged the advantage is unfair, but argued women should use it rather than ignore it. "If it's going to make me more money to paint my face, clown me up," she said.

Diamond's findings suggest weight bias may work in a similar way. Women who were already employed when they began taking GLP-1s did not see higher pay or greater odds of promotion. The biggest gains appeared among women who were unemployed and trying to enter the workforce.

Losing weight does not make someone smarter, more capable, more hardworking or qualified for a job. But it may change how other people perceive them.

That is what makes these findings so uncomfortable. If some women receive more opportunities after losing weight even though their underlying abilities have not changed, the economic benefit may reflect how strongly appearance can shape the way women are perceived and treated.

What To Read Next

Join 250,000+ readers and get Moneywise's best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.

This article originally appeared on Moneywise.com under the title: Harvard study links GLP-1 weight-loss drugs to a 27-point jump in women's employment — bigger than a college degree gap

This article provides information only and should not be construed as advice. It is provided without warranty of any kind.

联系我们 contact @ memedata.com